advisory committee

Optimer Pharma Jumps After Stock Grants, Ahead of FDA Advisory Meeting

Each stock option has an exercise price per share equal to $11.83, the fair market value on the grant date, and vests over four years, with 25% of the shares vesting on the one-year anniversary of the applicable vesting commenceme

advisory committee, board, diarrhea, drug, fda, fidaxomicin, financial, infection, medical, optimer, optr, patient, pharma, shares, stock, treatment

Optimer Pharmaceuticals (OPTR) says that on March 31, its Board approved the grant of inducement stock options to purchase an aggregate of 258,000 shares of common stock to 7 new employees.

By FNNO Staff
fnnonline@gmail.com

Latest News from FNNO

XL Capital Looks to Continue to Trade Ab...

Shares of XL Capital (NYSE:XL) traded today at $35.52, breaking its 52-week high. So f ...

Skechers U.S.A. Makes a Move: Up 1.3%...

Skechers U.S.A. (NYSE:SKX) is one of today's biggest movers, up 1.3% to $54.10. The Do ...

Deckers Outdoor Shares Sinking Lower, Do...

Deckers Outdoor (NASDAQ:DECK) is one of today's biggest movers, down 1.3% to $89.57. T ...

Verizon Communications: The Winning Stre...

Verizon Communications (NYSE:VZ) traded at a new 52-week high today of $53.66. So far ...

Stock Investors Sell Off Shares of Shutt...

Shutterfly (NASDAQ:SFLY), a company whose shares are moving quickly, is trading 1.3% lo ...

Watch for Continued Gains in Shares of U...

Shares of Universal Health Services (NYSE:UHS) traded today at $110.43, breaking its 52 ...

Stock Investors Sell Off Shares of Lulul...

Lululemon Athletica (NASDAQ:LULU) is a company whose shares are active, trading 1.3% lo ...

Shares of UDR Have Risen Above Previous ...

Shares of UDR (NYSE:UDR) traded at a new 52-week high today of $29.36. This new high w ...

Most Popular Video News